Dietary supplement of plant origin for the proper functioning of the liver and gallbladder and to improve digestion
Description
A combination preparation containing plant extracts, which act on the liver and gallbladder and, due to their wide range of action, are traditionally used in phytotherapy as an adjunctive means, as well as in the treatment of various dysfunctions and diseases.
Contains the natural substance silymarin derived from milk thistle for the protection and strengthening of the liver, artichoke for stimulating the liver and gallbladder system, as well as the valuable lecithin improving thus the function of digestion.
Properties
Contributes to the management of chronic inflammatory liver diseases, while acting adjunctively in cases of alteration of the hepatic parenchyma. Helps in the metabolism through the liver and contributes to its regeneration rate. Activates the flow of bile fluid in cases of dyspepsia and stimulates the secretion of pancreatic fluid.
NUTRITIONAL COMPONENT TABLE |
|
| Composition per daily dose | 2 capsules |
| Lecithin | 300mg |
| Milk thistle extract | 250mg |
| of which silymarin | 200mg |
| Artichoke extract | 100mg |
Ingredients : Soy lecithin (27%), milk thistle extract (22%), hydroxypropyl methylcellulose (capsule shell), filler: carob bean fiber, artichoke extract (9%).
Recommended daily intake: 2 capsules daily (morning-evening) half an hour before a meal.
Form - Packaging: 60 capsules
Warnings:
- Allergies to any of the ingredients. Patients who have had bile removal or have a stone in the bile. There is no experience of HEPAVERDE 100 during pregnancy and lactation and therefore its use in these cases is contraindicated.
- Do not exceed the recommended daily dose.
- Dietary supplements should not be used as a substitute for a balanced diet.
- The product is not intended for the prevention, treatment or diagnosis of a human disease.
- Consult your doctor if you are pregnant, breastfeeding, on medication or have health problems.
- Keep away from children.
Code EOPH: 14186/25-02-2015
The notification number in EOPH does not imply a marketing authorization from EOPH.










